-
1 Comment
Premier, Inc is currently in a long term uptrend where the price is trading 2.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.8.
Premier, Inc's total revenue rose by 32.3% to $423M since the same quarter in the previous year.
Its net income has increased by 20.5% to $44M since the same quarter in the previous year.
Finally, its free cash flow fell by 32.5% to $66M since the same quarter in the previous year.
Based on the above factors, Premier, Inc gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Health Information Services |
| CurrencyCode | USD |
| ISIN | US74051N1028 |
| Exchange | NASDAQ |
| PE Ratio | 166.24 |
|---|---|
| Market Cap | 2B |
| Beta | 0.61 |
| Dividend Yield | 3.0% |
| Target Price | 28.25 |
Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. The company offers solutions for providers, such as group purchasing organization, supply chain optimization, margin improvement, workforce management, care transformation, value-based care, and provider collaboratives; for suppliers, such as group purchasing organization and digital supply chain; for life sciences, such as real-world evidence, research, real-world data, healthcare professional, engagement solutions, improvement science, and premier applied sciences team; and for payers, such as coding guide for payers, prior authorization, and gaps. It offers services, including data and analytics, supply chain solutions, software-as-a-service informatics and consulting, and group purchasing. It serves a network of hospitals, health systems, and other healthcare providers. The company was incorporated in 2013 and is based in Charlotte, North Carolina. As of November 25, 2025, Premier, Inc. operates as a subsidiary of Patient Square Capital, LP.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for PINC using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026